Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the ...

Merck's 2025 revenue forecast fell short of Wall Street expectations, following the company's decision to temporarily halt shipments of its cancer vaccine, Gardasil, to China, CNBC reported Feb. 4.

Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...

(Bloomberg) -- Merck & Co.’s blockbuster vaccine Gardasil ... Cecolin, a bivalent HPV shot developed by Beijing Wantai Biological Pharmacy Enterprise Co., for example, costs under 1,000 yuan ...

A month has gone by since the last earnings report for Merck (MRK). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

Plus, access to 150 markets across 34 countries and the Zacks Rank Trading Tool. Merck is one of the world's largest pharmaceutical companies. Merck reported 4% revenue growth in the third quarter ...